Current Clinical Microbiology Reports最新文献_第7页

Persistence in Livestock Mycoplasmas—a Key Role in Infection and Pathogenesis 家畜支原体的持久性:感染和发病的关键作用

IF 5.2

Current Clinical Microbiology Reports Pub Date : 2020-07-24 DOI: 10.1007/s40588-020-00149-1

K. Hoelzle, Julia Ade, L. Hoelzle

引用次数: 11

Picornavirus Cellular Remodeling: Doubling Down in Response to Viral-Induced Inflammation. 皮卡病毒细胞重塑：加倍努力应对病毒引发的炎症

IF 3.1

Current Clinical Microbiology Reports Pub Date : 2020-06-01 Epub Date: 2020-04-17 DOI: 10.1007/s40588-020-00138-4

Alexis Bouin, Bert L Semler

引用次数: 0

Biology and function of exo-polysaccharides from human fungal pathogens. 人真菌病原菌外多糖的生物学和功能。

IF 5.2

Current Clinical Microbiology Reports Pub Date : 2020-03-01 Epub Date: 2020-01-17 DOI: 10.1007/s40588-020-00137-5

Krystal Y Chung, Jessica C S Brown

引用次数: 3

Correction to: Herpesvirus DNA Polymerase Mutants—How Important Is Faithful Genome Replication? 更正：疱疹病毒DNA聚合酶突变体——忠实的基因组复制有多重要？

IF 5.2

Current Clinical Microbiology Reports Pub Date : 2020-01-27 DOI: 10.1007/s40588-019-00136-1

J. Trimpert, N. Osterrieder

引用次数: 0

Reactive Arthritis: Update. 反应性关节炎:更新。

IF 5.2

Current Clinical Microbiology Reports Pub Date : 2020-01-01 Epub Date: 2020-09-26 DOI: 10.1007/s40588-020-00152-6

Ibtissam Bentaleb, Kawther Ben Abdelghani, Samira Rostom, Bouchra Amine, Ahmed Laatar, Rachid Bahiri

{"title":"Reactive Arthritis: Update.","authors":"Ibtissam Bentaleb, Kawther Ben Abdelghani, Samira Rostom, Bouchra Amine, Ahmed Laatar, Rachid Bahiri","doi":"10.1007/s40588-020-00152-6","DOIUrl":"https://doi.org/10.1007/s40588-020-00152-6","url":null,"abstract":"Purpose of review: The aim of this paper is to provide an overview about reactive arthritis, with an update regarding pathophysiology and therapeutic approach of the disease, outlining the clinical features and diagnostic approach, based on recent literature review.Recent findings: Reactive arthritis is considered to be part of the spectrum of the spondyloarthritis. Its epidemiology is changing worldwide due to several reasons, among them are as follows: different diagnosis approach and clinical presentations, different grades of infection, microbiome changes, etc. The understanding of pathophysiological models is challenging, but recent studies contribute to elucidate the major factors involved in the development of the disease. The management of ReA depends on the triggering agent and the phase of disease, whether it is acute or chronic.Summary: The association between the microbiome changes and spondyloarthropathies (ReA) is becoming increasingly evident. The results regarding the biologic treatment on refectory ReA are promising.","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"7 4","pages":"124-132"},"PeriodicalIF":5.2,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40588-020-00152-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38453057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 12

Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival. 剥夺病毒的铁元素供应是一种很有前景的病毒生存辅助疗法

IF 3.1

Current Clinical Microbiology Reports Pub Date : 2020-01-01 Epub Date: 2020-04-20 DOI: 10.1007/s40588-020-00140-w

Wei Liu, Shuping Zhang, Sergei Nekhai, Sijin Liu

{"title":"Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival.","authors":"Wei Liu, Shuping Zhang, Sergei Nekhai, Sijin Liu","doi":"10.1007/s40588-020-00140-w","DOIUrl":"10.1007/s40588-020-00140-w","url":null,"abstract":"Purpose of the review: The ongoing outbreak of novel coronavirus pneumonia (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) in China is lifting widespread concerns. Thus, therapeutic options are urgently needed, and will be discussed in this review.Recent findings: Iron-containing enzymes are required for viruses most likely including coronaviruses (CoVs) to complete their replication process. Moreover, poor prognosis occurred in the conditions of iron overload for patients upon infections of viruses. Thus, limiting iron represents a promising adjuvant strategy in treating viral infection through oral uptake or venous injection of iron chelators, or through the manipulation of the key iron regulators. For example, treatment with iron chelator deferiprone has been shown to prolong the survival of acquired immunodeficiency syndrome (AIDS) patients. Increasing intracellular iron efflux via increasing iron exporter ferroportin expression also exhibits antiviral effect on human immunodeficiency virus (HIV). The implications of other metals besides iron are also briefly discussed.Summary: For even though we know little about iron regulation in COVID-19 patients thus far, it could be deduced from other viral infections that iron chelation might be an alternative beneficial adjuvant in treating COVID-19.","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"7 2","pages":"13-19"},"PeriodicalIF":3.1,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169647/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37857556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

TRIM Proteins in Host Defense and Viral Pathogenesis. 宿主防御和病毒致病过程中的 TRIM 蛋白质

IF 5.2

Current Clinical Microbiology Reports Pub Date : 2020-01-01 Epub Date: 2020-08-08 DOI: 10.1007/s40588-020-00150-8

Maria I Giraldo, Adam Hage, Sarah van Tol, Ricardo Rajsbaum

{"title":"TRIM Proteins in Host Defense and Viral Pathogenesis.","authors":"Maria I Giraldo, Adam Hage, Sarah van Tol, Ricardo Rajsbaum","doi":"10.1007/s40588-020-00150-8","DOIUrl":"10.1007/s40588-020-00150-8","url":null,"abstract":"Purpose of review: Tripartite motif (TRIM) proteins are a large group of E3 ubiquitin ligases involved in different cellular functions. Of special interest are their roles in innate immunity, inflammation, and virus replication. We discuss novel roles of TRIM proteins during virus infections that lead to increased pathogenicity.Recent findings: TRIM proteins regulate different antiviral and inflammatory signaling pathways, mostly by promoting ubiquitination of important factors including pattern recognition receptors, adaptor proteins, kinases, and transcription factors that are involved in type I interferon and NF-κB pathways. Therefore, viruses have developed mechanisms to target TRIMs for immune evasion. New evidence is emerging indicating that viruses have the ability to directly use TRIMs and the ubiquitination process to enhance the viral replication cycle and cause increased pathogenesis. A new report on TRIM7 also highlights the potential pro-viral role of TRIMs via ubiquitination of viral proteins and suggests a novel mechanism by which ubiquitination of virus envelope protein may provide determinants of tissue and species tropism.Summary: TRIM proteins have important functions in promoting host defense against virus infection; however, viruses have adapted to evade TRIM-mediated immune responses and can hijack TRIMs to ultimately increase virus pathogenesis. Only by understanding specific TRIM-virus interactions and by using more in vivo approaches can we learn how to harness TRIM function to develop therapeutic approaches to reduce virus pathogenesis.","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"7 4","pages":"101-114"},"PeriodicalIF":5.2,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414267/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38303059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Utilizing Microbes to Treat Naturally Occurring Cancer in Veterinary Species 利用微生物治疗兽医物种中自然发生的癌症

IF 5.2

Current Clinical Microbiology Reports Pub Date : 2019-12-01 DOI: 10.1007/s40588-019-00130-7

S. Withers, E. Sparger, B. Boudreaux, N. Mason

引用次数: 0

Listeria monocytogenes cancer vaccines: bridging innate and adaptive immunity. 单核细胞增生李斯特菌癌症疫苗:桥接先天免疫和适应性免疫。

IF 5.2

Current Clinical Microbiology Reports Pub Date : 2019-12-01 Epub Date: 2019-11-20 DOI: 10.1007/s40588-019-00133-4

Zachary T Morrow, Zachary M Powers, John-Demian Sauer

{"title":"Listeria monocytogenes cancer vaccines: bridging innate and adaptive immunity.","authors":"Zachary T Morrow, Zachary M Powers, John-Demian Sauer","doi":"10.1007/s40588-019-00133-4","DOIUrl":"https://doi.org/10.1007/s40588-019-00133-4","url":null,"abstract":"Purpose of the review: Immunotherapy has emerged as a promising cancer treatment, however success in only select clinical indications underscores the need for novel approaches. Recently Listeria monocytogenes-based vaccines have been developed to drive tumor specific T-cell responses. Here, we discuss recent preclinical studies using L. monocytogenes vaccines, innate immune pathways that influence T-cell priming, and new vaccine strategies in clinical trials.Recent findings: Recent studies indicate that in addition to inducing antigen specific T-cell responses, L. monocytogenes vaccines remodel the TME. In addition, several innate immune pathways influence adaptive immune responses to L. monocytogenes and modulating these pathways holds promise to enhance anti-tumor T-cell responses.Summary: The interplay between innate and adaptive immune responses to L. monocytogenes is poorly understood. Understanding these interactions will facilitate the design of better anti-cancer vaccines and improved use of combination therapies.","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"6 4","pages":"213-224"},"PeriodicalIF":5.2,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40588-019-00133-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38502086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 12

Viral genetic diversity and its potential contributions to the development and progression of neonatal herpes simplex virus (HSV) disease. 病毒遗传多样性及其对新生儿单纯疱疹病毒(HSV)疾病的发展和进展的潜在贡献

IF 5.2

Current Clinical Microbiology Reports Pub Date : 2019-12-01 Epub Date: 2019-11-23 DOI: 10.1007/s40588-019-00131-6

Lisa N Akhtar, Moriah L Szpara

{"title":"Viral genetic diversity and its potential contributions to the development and progression of neonatal herpes simplex virus (HSV) disease.","authors":"Lisa N Akhtar, Moriah L Szpara","doi":"10.1007/s40588-019-00131-6","DOIUrl":"10.1007/s40588-019-00131-6","url":null,"abstract":"Purpose of review: Neonatal infection by herpes simplex virus (HSV) 1 or 2 presents a devastating burden to new parents, due to the unpredictability of severe clinical outcomes, as well as the potential for lifelong reactivation. While just under half of neonatal HSV infections have mild clinical impacts akin to those observed in adults, the other half experience viral spread throughout the body (disseminated infection) and/or the brain (central nervous system infection).Summary: Here we summarize current data on clinical diagnostic measures, antiviral therapy, and known factors of human host biology that contribute to the distinct neonatal outcomes of HSV infection.Recent findings: We then explore recent new data on how viral genetic diversity between infections may impact clinical outcomes. Further research will be critical to build upon these early findings and to provide statistical power to our ability to discern and/or predict the potential clinical path of a given neonatal infection.","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"6 4","pages":"249-256"},"PeriodicalIF":5.2,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40588-019-00131-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38392150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2